Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/44843

Type
Article
Copyright
Restricted access
Collections
Share

Statistics
Metadata
Show full item record

SEVERE NECROTISING TOXOPLASMIC RETINOCHOROIDITIS IN A PATIENT WITH CROHN'S DISEASE IN USE OF ADALIMUMAB AND AZATHIOPRINE
Biancardi, Ana Luiza et al. | Date Issued: 2020
Author
Biancardi, Ana Luiza
Costa, Joana Breves
Azevedo, Leonardo Gomes Bortoloti de
Moraes, Haroldo Vieira de
Barroso, Paulo Feijó
Zaltman, Cyrla
Affilliation
Oswaldo Cruz Foundation. National Institute of Infectology Evandro Chagas. Laboratory of Ophthalmology. Rio de Janeiro, RJ, Brazil.
Federal University of Rio de Janeiro. Gastroenterology Division. Department of Internal Medicine. Rio de Janeiro, RJ, Brazil.
Federal University of Rio de Janeiro. Ophthalmology Department. Rio de Janeiro, RJ, Brazil.
Federal University of Rio de Janeiro. Ophthalmology Department. Rio de Janeiro, RJ, Brazil.
Federal University of Rio de Janeiro. Infectology Department. Rio de Janeiro, RJ, Brazil.
Federal University of Rio de Janeiro. Gastroenterology Division. Department of Internal Medicine. Rio de Janeiro, RJ, Brazil.
Keywords
inflammatory bowel disease
Crohn’s disease
Toxoplasmosis
Ocular disease
 
Citation
BIANCARDI Ana Luiza et al. Severe Necrotising Toxoplasmic Retinochoroiditis in a Patient With Crohn's Disease in Use of Adalimumab and Azathioprine. Inflammatory Bowel Diseases, v. 26, n. 7, p. e69–e70, July 2020.
DOI
10.1093/ibd/izaa105
ISSN
1536-4844